Psychopharmacology News and Research

RSS

Psychopharmacology is the study of drug-induced changes in mood, sensation, thinking, and behavior.

Truly random drug testing: ADHD patients face uneven urine screens and, sometimes, stigma

Some adults who take prescription medication for attention-deficit/hyperactivity disorder are required to have their urine tested for drugs several times a year. Others never are tested.

28 Mar 2023

Speech pattern analysis can help diagnose, manage psychiatric disorders

Objective measurement of psychiatric disorders has long proved challenging. Yet, there is ample evidence that analysis of speech patterns can accurately diagnose depression and psychosis, measure their severity, and predict their onset, according to a literature review featured in the January/February issue of the Harvard Review of Psychiatry.

9 Jan 2023

Expert panel recommends revisions to gender-affirming care guidelines

Transgender and gender-diverse (TGD) people often seek social, medical, and surgical gender-affirming care from a variety of healthcare professionals.

19 Dec 2022

Johns Hopkins researchers characterize a broad range of psychedelic occasioned belief changes

Johns Hopkins Medicine researchers continue their exploration into psychedelics and how these drugs may produce a wide range of profound changes in perception, cognition and mood.

9 Dec 2022

Lifestyle interventions can help pediatricians meet the growing need for youth depression management

With rising prevalence of depression in adolescents, screening requirements are increasingly falling on pediatric primary care providers, who are encountering more at-risk patients.

15 Sep 2022

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

More than six percent of Americans will develop posttraumatic stress disorder (PTSD) in their lifetime. This potentially chronic condition disrupts lives, and can lead to or exacerbate existing health issues such as depression, anxiety, eating disorders, and suicidal thoughts.

22 Aug 2022

High-dose supplementation of Vitamin B6 decreases anxiety

Researchers reported that vitamin B6 supplementation reduced anxiety.

25 Jul 2022

High-dose Vitamin B6 tablets could reduce feelings of anxiety and depression

Taking high-dose Vitamin B6 tablets has been shown to reduce feelings of anxiety and depression by new research.

19 Jul 2022

New Oxford study examines the effectiveness of pharmacological treatments for insomnia

Two drugs, eszopiclone and lemborexant - both not currently licenced for the treatment of insomnia in the UK - were shown to perform better than others, both in the acute and long-term treatment of insomnia in adults, according to a new Oxford study exploring the pharmacological management of insomnia.

19 Jul 2022

Could Vitamin B6 Reduce Anxiety and Depression?

In this interview, we speak to Dr. David Field about his latest research into anxiety and depression and whether vitamin B6 supplements could help to reduce it.

19 Jul 2022

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Millions of consumers and patients around the world will be heartened by the results of the latest study on cannabis and driving.

30 May 2022

Treating pediatric psychiatric disorders with psychotropic drugs reduces later substance use disorder risk

One half of psychiatric and substance use disorders start by the age of 18; three-quarters by age 24. While these are concerning statistics, a new study from Massachusetts General Hospital finds that treating psychiatric disorders with psychotropic medications in children and adolescents does not increase the risk of developing substance use, misuse, or substance use disorder (SUD).

19 May 2022

Neuroimaging advances show promise in helping transcranial electrical stimulation to effectively treat visual hallucinations

A literature review in Harvard Review of Psychiatry indicates that, while transcranial electrical stimulation (tES) has rarely been used in treating visual hallucinations (VH) among patients with psychiatric disorders, recent advances in neuroimaging technology show promise in helping tES to more effectively treat VH in psychiatric disorders where VH are a core symptom.

13 May 2022

Two doses of psilocybin may ease depression symptoms for up to 12 months

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month.

15 Feb 2022

One in five young adults with substance use disorder may have undiagnosed autistic traits

One in five teens and young adults who seek treatment for alcohol or drug use may have traits characteristic of a previously unrecognized autism spectrum disorder (ASD), researchers at Massachusetts General Hospital (MGH) report.

25 Jan 2022

Study offers new evidence on how childhood immunometabolic risk factors may lead to depression, psychosis

A growing body of research suggests that early-life infection, inflammation, and metabolic changes could contribute to psychiatric disorders – perhaps via effects during critical periods of brain development.

11 Jan 2022

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

New research from the Institute of Psychiatry, Psychology, & Neuroscience (IoPPN) at King's College London, in partnership with COMPASS Pathways, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants simultaneously.

4 Jan 2022

Psychopharmacology News and Research

Further Reading

Truly random drug testing: ADHD patients face uneven urine screens and, sometimes, stigma

Speech pattern analysis can help diagnose, manage psychiatric disorders

Expert panel recommends revisions to gender-affirming care guidelines

Johns Hopkins researchers characterize a broad range of psychedelic occasioned belief changes

Lifestyle interventions can help pediatricians meet the growing need for youth depression management

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

High-dose supplementation of Vitamin B6 decreases anxiety

High-dose Vitamin B6 tablets could reduce feelings of anxiety and depression

New Oxford study examines the effectiveness of pharmacological treatments for insomnia

Could Vitamin B6 Reduce Anxiety and Depression?

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Treating pediatric psychiatric disorders with psychotropic drugs reduces later substance use disorder risk

Neuroimaging advances show promise in helping transcranial electrical stimulation to effectively treat visual hallucinations

Two doses of psilocybin may ease depression symptoms for up to 12 months

One in five young adults with substance use disorder may have undiagnosed autistic traits

Study offers new evidence on how childhood immunometabolic risk factors may lead to depression, psychosis

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

Antipsychotic drugs associated with increase in risk of breast cancer

Caffeine increases alertness and detection accuracy for moving targets

Treating depression with an app

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News